会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • ORGANIC COMPOUNDS
    • 有机化合物
    • WO2005074926A1
    • 2005-08-18
    • PCT/US2005/003427
    • 2005-01-28
    • NOVARTIS AGOTTLECZ, AnnaGIGER, Rudolf, Karl, AndreasALVAREZ, Carlos
    • OTTLECZ, AnnaGIGER, Rudolf, Karl, AndreasALVAREZ, Carlos
    • A61K31/44
    • A61K31/44
    • The present invention provides methods and uses of imidazolylalkyl-pyridines in the treatment of ocular disorders. A first aspect of the invention provides a method of treating ocular neovascularization comprising administering to a subject in need of such treatment a therapeutically effective amount of a compound having the formula (I) in free base or physiologically acceptable acid addition salt form, wherein R 1 .is hydrogen, lower alkyl, halogen with an atomic number of 9 to 35 or amino optionally mono- or disubstituted by lower alkyl, R 2 . and R 3 . independently of one another are hydrogen or lower alkyl, R 4 . is hydrogen, hydroxy, lower alkyl, lower alkoxy or halogen with an atomic number of 9 to 35, and the bridge between the pyridine and the imidazole, illustrated as methylene, is methylene or ethylene.
    • 本发明提供咪唑烷基 - 吡啶类治疗眼部疾病的方法和用途。 本发明的第一方面提供了一种治疗眼新生血管形成的方法,包括向需要这种治疗的受试者施用治疗有效量的游离碱或生理学上可接受的酸加成盐形式的式(I)化合物,其中R1。 是氢,低级烷基,原子数为9至35的卤素或任选被低级烷基R2单取代或二取代的氨基。 和R3。 独立地是氢或低级烷基,R4。 是氢原子,羟基,低级烷基,低级烷氧基或卤素,原子序数为9至35,吡啶和咪唑之间的桥接,亚甲基是亚甲基或亚乙基。